<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000751152">
  <TermName>OPPA regimen</TermName>
  <TermPronunciation>(... REH-jih-men)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>An abbreviation for a chemotherapy combination that is often used with radiation therapy to treat a certain type of childhood Hodgkin lymphoma in females. It includes the drugs vincristine sulfate (Oncovin), prednisone, procarbazine hydrochloride, and doxorubicin hydrochloride (Adriamycin). Also called OPPA.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000752519" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;OPPA regimen&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000752520" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen OPPA&quot;" language="es" id="_4"/>
  <SpanishTermName>régimen OPPA</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Nombre de  una quimioterapia combinada que a menudo se usa con radioterapia para el tratamiento de cierto tipo de linfoma de Hodgkin infantil en niñas. Incluye los medicamentos sulfato de vincristina (Oncovin), prednisona, clorhidrato de procarbazina y clorhidrato de doxorrubicina (Adriamycin). También se llama OPPA.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2013-07-17</DateFirstPublished>
  <DateLastModified>2013-09-20</DateLastModified>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000750859" url="/about-cancer/treatment/drugs/OPPA">OPPA</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
